Amarin

No News Equals Bad News for Amarin Investors
Motley Fool
Sat, 11/17/12 - 02:05 pm
Amarin
Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delay
The Street
Sat, 11/17/12 - 02:01 pm
Amarin
Vascepa
fish oil
3 Potential Partners for Amarin
Motley Fool
Thu, 11/15/12 - 10:43 am
M&A
Amarin
AstraZeneca
Merck
Eli Lilly
Amarin's Dilemma: Sell Vascepa Or Sell Itself?
Seeking Alpha
Tue, 11/13/12 - 11:16 am
Amarin
Vascepa
Amarin Releases Q3 Results: What You Need To Know
Seeking Alpha
Mon, 11/12/12 - 11:27 am
earnings
Amarin
Biotech Weekend Recap: Important Developments And Big Releases
Seeking Alpha
Sun, 11/11/12 - 09:49 am
Amarin
Vivus
Dendreon
Arena Pharmaceuticals
Pharmacyclics
Biomarin
Amarin Still Playing the Dating Game
Motley Fool
Sun, 11/11/12 - 09:31 am
Amarin
Vascepa
Amarin Still Playing the Dating Game
Motley Fool
Fri, 11/9/12 - 09:50 am
Amarin
M&A
AstraZeneca
Does Amarin Need the FDA to Play NCE?
Motley Fool
Fri, 11/9/12 - 08:53 am
Amarin
Vascepa
FDA
NCE
Amarin Stagnates On Frustrating M&A Speculation And (More) Waiting
Seeking Alpha
Wed, 11/7/12 - 11:22 am
M&A
Amarin
GSK
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
biotech
M&A
Amarin
Achillion
ONYX Pharmaceuticals
Actelion
Elan
Forest Labs
Medivation
Biomarin
Indenix
How Do You Solve a Problem Like Vascepa?
Motley Fool
Mon, 11/5/12 - 11:01 am
Vascepa
Amarin
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Fri, 11/2/12 - 10:26 am
patents
Amarin
AstraZeneca
Bristol-Myers Squibb
GSK
3 Biotechs Investors Should Be Scared Of
Motley Fool
Wed, 10/31/12 - 11:40 am
Amarin
Alexion
Spectrum Pharmaceuticals
Why These 3 Biotech Stocks Are Winning
Motley Fool
Sat, 10/27/12 - 11:32 am
Cyclacel
Gilead Sciences
Amarin
AstraZeneca may launch cash bid for Amarin, Daily Mail reports
Yahoo/Fly on the Wall
Wed, 10/24/12 - 10:59 am
AstraZeneca
M&A
Amarin
Wall Street Loves Amarin. Should You?
Motley Fool
Mon, 10/22/12 - 10:31 am
Amarin
Vascepa
Amarin strength attributed to pervious comments in peer review journal
Yahoo/Fly on the Wall
Thu, 10/18/12 - 12:48 pm
Amarin
3 Biotechs With Good FDA News
Motley Fool
Wed, 10/17/12 - 11:49 am
FDA
Arqule
Threshold Pharmaceuticals
Amarin
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sun, 10/14/12 - 11:04 am
Eli Lilly
Valeant Pharmaceuticals
Lexicon Pharmaceuticals
Sarepta Therapeutics
Amarin
NPS Pharmaceuticals
Aeterna Zentaris

Pages